Excelente aplicación
Todos los días la utilizo! lo máximo
Description
¤ Calculator and Clinical Decision Support Systems based on AAP 2022 and NICE 2016 guidelines for the management of hyperbilirubinemia in newborns.
Features:
¤ Risk curve by gestational age at birth.
¤ Algorithms for clinical decision making (AAP 2022).
¤ Calculations in mg/dl and µmol/L
¤ Extended graphs from 0 to 336 hours (0-14 Days)
¤ Original and easier-to-interpret graphs
¤ Neurotoxicity risk factors absent, present.
¤ Plot up to 2 time points to assess trends.
¤ Rate of increase between the last two measurements, if this is in danger range.
¤ Age in hours from birth dates to measurements.
This application was designed and programmed by Gerson Rodriguez Quintero, Pediatrician from Universidad Del Norte, Colombia. Please contact me if you notice any discrepancies.
Hide
Show More...
Features:
¤ Risk curve by gestational age at birth.
¤ Algorithms for clinical decision making (AAP 2022).
¤ Calculations in mg/dl and µmol/L
¤ Extended graphs from 0 to 336 hours (0-14 Days)
¤ Original and easier-to-interpret graphs
¤ Neurotoxicity risk factors absent, present.
¤ Plot up to 2 time points to assess trends.
¤ Rate of increase between the last two measurements, if this is in danger range.
¤ Age in hours from birth dates to measurements.
This application was designed and programmed by Gerson Rodriguez Quintero, Pediatrician from Universidad Del Norte, Colombia. Please contact me if you notice any discrepancies.
Screenshots
BiliAAP FAQ
-
Is BiliAAP free?
BiliAAP is not free (it costs 4400.00), however it doesn't contain in-app purchases or subscriptions.
-
Is BiliAAP legit?
‼️️ The BiliAAP app seems suspicious. Many reviews appear fake or manipulated. Exercise caution.
Thanks for the vote -
How much does BiliAAP cost?
The price of BiliAAP is 4400.00.
-
What is BiliAAP revenue?
To get estimated revenue of BiliAAP app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in South Korea yet.
Ratings History
BiliAAP Reviews
Reseña
Lo mejor que me ha pasado, vale cada peso
Muy buena
Excelente app
Muy buena
Excelente aplicación, optimiza mi tiempo al máximo. 100% recomenda, muy práctica.
Excelente aplicación!
De las mejores apps médicas que he usado, facilita un montón la práctica. 100% recomendada.
Muy buena
Muy útil, hace todo más fácil
Muy útil
Vital en mi práctica diaria como profesional de la salud
La mejor app del mundo
Muy buena
Excelente
Excelente, súper útil
Excelente app
La mejor !
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
|
Chart
|
Category
|
Rank
|
|---|---|---|
|
Top Paid
|
|
2
|
|
Top Paid
|
|
3
|
|
Top Paid
|
|
4
|
|
Top Paid
|
|
5
|
|
Top Paid
|
|
8
|
BiliAAP Competitors
| Name | Downloads (30d) | Monthly Revenue | Reviews | Ratings | Recent release | |
|---|---|---|---|---|---|---|
Ped(z) - Pediatric Calculator
|
Unlock
|
Unlock
|
0
|
|
3 months ago | |
NeoTPN
Neonatal Tpn Calculations
|
Unlock
|
Unlock
|
0
|
|
2 years ago | |
Antibiogram Reading
Antibiogram Reading Assistant
|
Unlock
|
Unlock
|
0
|
|
8 months ago | |
UmbiCalc
Insertion Length Calculator
|
Unlock
|
Unlock
|
0
|
|
2 years ago | |
Percentilez
Monitor children's growth
|
Unlock
|
Unlock
|
0
|
|
3 years ago | |
BiliBuddy
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
Simple Ballard Score
Gestational Age Assessment
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
PICU Calculator
|
Unlock
|
Unlock
|
0
|
|
2 years ago | |
Pediadosis
Medicamentos en Pediatría
|
Unlock
|
Unlock
|
0
|
|
6 days ago | |
Pedexp
Pediatric Exploration
|
Unlock
|
Unlock
|
0
|
|
9 months ago |
BiliAAP Installs
Last 30 days
BiliAAP Revenue
Last 30 daysBiliAAP Revenue and Downloads
Gain valuable insights into BiliAAP performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
-
Gerson Rodriguez
- Languages
- Recent release
- MAUI 3.0 (2 months ago )
- Released on
- Nov 1, 2022 (2 years ago )
- Also available in
- Colombia , United States , Mexico , Peru , Ecuador , Chile , Thailand , Ireland , Lithuania , Lebanon , Kazakhstan , Malaysia , Kuwait , Nigeria , Netherlands , Norway , New Zealand , South Korea , Poland , Philippines , Pakistan , India , Portugal , Romania , Russia , Saudi Arabia , Sweden , Singapore , Türkiye , Taiwan , Ukraine , Vietnam , South Africa , Dominican Republic , Argentina , Austria , Australia , Azerbaijan , Belgium , Brazil , Belarus , Canada , Switzerland , China , Czechia , Germany , Denmark , Japan , Algeria , Egypt , Spain , Finland , France , United Kingdom , Greece , Hong Kong SAR China , Hungary , Indonesia , Israel , United Arab Emirates , Italy
- Last Updated
- 6 days ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.